FDA Clearance Tracker · K160265
Image Navigator by Immuno Concepts
Last checked: Nov 20, 2026Latest source record: Jun 17, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Jun 17, 2016
Substantially Equivalent
Time to decision
136 days
Received Feb 2, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K160265
- Device name
- Image Navigator by Immuno Concepts
- Applicant
- Immuno Concepts, N.A. , Ltd.
- Applicant location
- Sacramento, CA
- Received
- Feb 2, 2016
- Decided
- Jun 17, 2016
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.5100
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DHN. The earliest in FDA's data is K760153, decided Jul 20, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K160265
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Immuno Concepts, N.A. , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K203599 · Decided May 26, 2023 · 898 days after receipt
Device type: Anti-Dna Indirect Immunofluorescent Solid Phase (KTL) · Laboratory Medicine & Pathology
K180202 · Decided Oct 19, 2018 · 268 days after receipt
Device type: Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control (DBL) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.